Unilever is unlikely to acquire GlaxoSmithKline’s consumer unit, UBS says

seekingalpha2022-01-21

JJFarquitectos/iStock Editorial via Getty Images After reaching a 52-week low on its failed bid to acquire the consumer unit of GlaxoSmithKline (GSK -1.1%), Unilever (UL -0.2%) ADRs rebounded ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2205099092?lang=zh_CN&edition=full","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1308621282/medium_image_1308621282.jpg","is_english":true,"pubTime":"2022-01-21 01:20","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2205099092","market":"us","top_or_hot":-1,"title":"Unilever is unlikely to acquire GlaxoSmithKline’s consumer unit, UBS says","media":"seekingalpha","content":"<div>\n<p>JJFarquitectos/iStock Editorial via Getty Images   After reaching a 52-week low on its failed bid to acquire the consumer unit of GlaxoSmithKline (GSK -1.1%), Unilever (UL -0.2%) ADRs rebounded ...</p>\n\n<a href=\"https://seekingalpha.com/news/3789758-unilever-is-unlikely-to-acquire-glaxosmithklines-consumer-unit-ubs-says\">网页链接</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Unilever is unlikely to acquire GlaxoSmithKline’s consumer unit, UBS says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUnilever is unlikely to acquire GlaxoSmithKline’s consumer unit, UBS says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-21 01:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3789758-unilever-is-unlikely-to-acquire-glaxosmithklines-consumer-unit-ubs-says><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>JJFarquitectos/iStock Editorial via Getty Images   After reaching a 52-week low on its failed bid to acquire the consumer unit of GlaxoSmithKline (GSK -1.1%), Unilever (UL -0.2%) ADRs rebounded ...</p>\n\n<a href=\"https://seekingalpha.com/news/3789758-unilever-is-unlikely-to-acquire-glaxosmithklines-consumer-unit-ubs-says\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4118","symbol_name":"综合性资本市场","start_time":0,"source_url":"https://seekingalpha.com/news/3789758-unilever-is-unlikely-to-acquire-glaxosmithklines-consumer-unit-ubs-says","article_id":"2205099092","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1308621282/medium_image_1308621282.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2205099092","pubTimestamp":1642699228,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"JJFarquitectos/iStock Editorial via Getty Images   After reaching a 52-week low on its failed bid to","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4118":"综合性资本市场","BK4207":"综合性银行","USB":"美国合众银行","UBS":"瑞银","BK4534":"瑞士信贷持仓","BK4559":"巴菲特持仓","BK4504":"桥水持仓"},"translate_title":"瑞银表示，联合利华不太可能收购葛兰素史克的消费者部门","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"UBS":1,"USB":1},"content_text":"JJFarquitectos/iStock Editorial via Getty Images   After reaching a 52-week low on its failed bid to acquire the consumer unit of GlaxoSmithKline (GSK -1.1%), Unilever (UL -0.2%) ADRs rebounded Wednesday as the company ruled out raising the bid any further.  Commenting on the development, UBS analysts led by Guillaume Delmas see Unilever’s (NYSE:UL) announcement as an attempt “to regain control of the narrative” and end the sharp volatility seen in its share price over the past three days. The deal for the division where Pfizer (NYSE:PFE) holds a minority stake is unlikely to happen, they added. Given that GlaxoSmithKline (NYSE:GSK) previously rejected £50B in December, citing the undervaluation of the unit and its prospects, “we now see the probability of Unilever acquiring GSK Consumer Health as particularly slim,” the analysts wrote. UBS has a Sell rating on Unilever (UL) with a price target of 3,700p, implying only a ~1.2% premium to the last close. Read why Bank of America said that the offer made by Unilever (UL) is unlikely to generate upside for the U.K. pharma giant.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2205099092"}